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1. Introduction 
Milk from humans [ 1,2] and gorillas [3] contains 
an inactive form of a lipase which becomes activated 
when the milk is mixed with intestinal contents. The 
activation of the enzyme is caused by interaction with 
certain bile salts [4]. This lipase contributes sub- 
stantially to the utilization of milk lipids by the new- 
born [5]. For instance, heat treatment of human milk 
inactivates the lipase [4] and reduces fat absorption 
by -1/3rd in pre-term infants [6]. This bile salt- 
stimulated lipase is not present in milk from rats, 
guinea pigs, rabbits, dogs, goats, cows, pigs or horses 
([l] unpublished). We now report a search for the 
evolutionary origin of this lipase. Two possibilities 
were considered: 
(i) The lipase might have evolved through a muta- 
tional change of some other milk protein; 
(ii) It might be a secretory protein from some other 
tissue which through a change in gene regulation 
has become expressed also by the milk producing 
cells. 
The results presented show that the lipase is closely 
related to a pancreatic protein but not to any of the 
other milk proteins. 
2. Materials and methods 
Fresh human milk was obtained from donors in 
Ume$. The Rhesus milk was collected in Beaverton, 
OR and transported frozen to Ume% The lipase 
activity in human milk is retained in samples stored 
frozen for several months [7]. Human pancreatic 
juice was obtained during cannulation of the pan- 
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creatic duct of a 57 year old female patient for 
diagnostic radiography. Human pancreatic tissue was 
obtained from the same patient at operation, 
immediately frozen and later homogenized in 0.01 M 
Tris-HCl, (pH 8). The procedures are detailed in 
figure legends. 
3. Results 
Rhesus milk showed no activity against long chain 
triglycerides emulsified in gum arabic whether bile 
salts were present or not (fig.1). This is in sharp con- 
SODIUM TAUROCHOLATE ImM) 
Fig.1. Effect of sodium taurocholate on lipase activity in 
milk from humans and from Rhesus monkey. The medium 
contained 3H-labeled triolein emulsified in gum arabic at 
pH 9 as detailed elsewhere [7]. The concentration of tauro- 
cholate was varied as indicated in the figure. Human milk 
(10 ~1) diluted loo-fold or undiluted Rhesus milk (10 ~1) 
was added. The final volume was 200 ~1. Incubation was at 
37°C for 15 min. 
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trast to human milk which hydrolyzed this emulsion 
rapidly in the presence of taurocholate. Since Rhesus 
milk might contain inhibitory factors which masked 
the activity in our in vitro assay a partial purification 
was attempted. Figure 2 shows chromatograms of 
human and of Rhesus whey proteins on heparin- 
Sepharose. In both cases most of the proteins eluted 
in the breakthrough fraction or early in the salt 
gradient causing relatively large peaks in the first 
9 fractions. Then followed peaks in fractions lo-12 
and 14- 16. These represent mainly serum albumin 
and lactoferrin, respectively [8]. Lipase activity was 
found in fractions 10-l 3 in the chromatography of 
human whey, but there was no activity in the frac- 
tions from Rhesus whey. Fraction 12 of human whey 
(corresponding to the peak of lipase activity) gave 3 
bands on SDS gels (fig.3). Further purification has 
indicated that the uppermost band is the lipase. 
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Fig.2. Chromatography of whey proteins on heparin--Se- 
pharose. To prepare whey, the milk was centrifuged 30 min at 
20 000 X g and the skim milk, acidified with HCl to pH 4.6, 
was heated at 40°C for 30 min to precipitate the caseins. The 
whey was dialyzed overnight against 0.05 M NaCl in 5 mM 
veronal_HCl buffer (pH 7.4). To a column of 1 ml settled 
heparin-Sepharose (prepared according to [9]) 4 ml was 
applied. The column was washed with 10 ml 5 mM veronal- 
HCl, 0.05 M NaCl (pH 7.4), then eluted with a 100 ml gra- 
dient of 0.05-l .O M NaCl in the same buffer. Fractions 
(4.5 ml) were collected and their content of bile salt- 
stimulated lipase (0) assayed as in fig.1 with taurocholate at 
10 mM. One unit (U) releases 1 umol fatty acid/min. 
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Fig.3. Polyacrylamide gel electrophoresis in sodium dodecyl 
sulfate (SDS) of fraction 12 from the chromatographies in 
fig.2. SDS and dithioerythritol were added to the samples to 
final cont. 1% (w/v) and 10 mM, respectively, then heated 
for 5 min at 90°C. Electrophoresis was according to [lo] on 
gels with 7% acrylamide. The gels were stained with Coomassie 
blue and destained as in [ 1 I]. 
Furthermore, this component becomes labeled when 
the preparation is incubated with radioactive diiso- 
propylfluorophosphate (DFP) which inactivates the 
lipase. It represents -1% of the human milk proteins. 
This band was not seen in fractions from Rhesus 
whey (fig.3). The other 2 bands were present in both 
human and Rhesus milk. They correspond to lacto- 
ferrin (upper band) and serum albumin (lower band). 
An antiserum raised against the purified lipase gave 
only one precipitate against human milk and no 
precipitate against human serum (fig.4). This indicates 
that the antiserum was monospecific. It inhibited the 
activity of the lipase, demonstrating that its reactivity 
was indeed directed against the lipase. This antiserum 
gave no precipitate against Rhesus milk (fig.4). It did, 
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Fig.4. Immunodiffusion of human milk, Rhesus milk and of 
human pancreatic proteins against a rabbit antiserum prepared 
towards purified bile salt-stimulated lipase from human milk. 
‘The antiserum reacted with the protein in the uppermost 
band seen on the SDS gel of human whey in fig.3, and 
inhibited the bile salt-stimulated lipase activity in human 
whey. The gel contained 1% agarose, 1.5 M NaCl (pH 8.5). 
The wells contained 15 ~1 human serum (S), a 10% 
homogenate of human pancreas (A), human milk (HM), 
human pancreatic juice (J) and Rhesus milk (RM) as 
indicated. The center well contained the antiserum. 
however, give precipitin lines with human pancreatic 
juice and with a homogenate of human pancreatic 
tissue (fig.4). These lines fused with that obtained 
with human milk, indicating immunological identity 
between the milk hpase and a secretory protein in the 
pancreas. The same result was obtained with pan- 
creatic juice from 5 other patients. 
4. Discussion 
A bile salt-dependent lipase was known to be 
present in milk from humans [l] and goritlas [3] but 
not in lower animals. Here we show that his lipase 
activity is not present in milk from Rhesus monkeys. 
Furthermore, there was no protein in Rhesus milk 
which reacted with the antiserum to the lipase or 
which resembled it in size or chromatographic 
behaviour. Thus, this lipase is an evolutionary new- 
comer which must have appeared somewhere between 
the Rhesus monkey and the gorilla. The driving force 
for its evolution was presumably a need to improve 
the utilization of milk lipids in general and/or some 
critical component in milk; e.g., the vitamin A esters 
[5]. In humans the exocrine pancreatic function is 
not fully developed at birth [5]. The provision of a 
lipase with the milk ensures that there is sufficient 
lipolytic activity for digestion of milk lipids in the 
intestine of the newborn. Since the enzyme is com- 
pletely without activity against the milk lipids until it 
becomes activated by bile salts [4] it can readily be 
secreted into the milk without doing any harm to 
the milk droplets while they are stored in the breast. 
Our results suggest hat the bile salt-stimulated 
lipase is a pancreatic protein, which in humans is 
secreted also by the lactating mammary gland. The 
presence of bile salt-stimulated lipases in the pancreas 
is well documented [12-161. Thus, the appearance of 
such an enzyme in milk may have been caused by a 
change in tissue specificity of gene expression rather 
than by a mutational change of some other milk 
protein. 
Acknowledgements 
We are grateful to Miss Kerstin Wiklund for her 
skillful technical assistance, and to Mrs Karin Gladh 
for preparing the lnanuscript. This work was supported 
by the Swedish Medical Research Council (19X- 
05708), The Wennergreska Samfundet, The Swedish 
Baby Food Industry Fund for Nutritional Research, 
The Swedish Nutrition Foundation, The Swedish 
Society of Medical Sciences, and the Medical Faculty, 
University of Ume”a. 
References 
[ 11 Freudenberg, E. (1953) Die Frauenmiich-lipase. 
S. Karger, Basel. 
[ 21 Hernell, 0. and Olivecrona, T. (1974) J. Lipid Res. 15, 
367-374. 
[3] Freudenberg, E. (1966) Experentia 22, 317. 
[4] Herneli, 0. (1975) Eur. 3. Chin. Invest. 5, 267-272. 
53 
Volume 112, number 1 FEBS LETTERS March 1980 
]5] Fredrikzon, B., Hernell, O., Bl$ckberg, L. and 
[S] BlZckberg, L. and Hernell, 0. (1980) FEBS Lett. 109, 
Olivecrona,T. (J978) Pediat. Res. 12, 1048-1052. 
]6] Williamson, S., Finucane, E., Ellis, H. and Gamsu, H. R. 
180-184. 
(1978) Arch. Dis. Childhood 53,555-563. 
[ 7) Herncll,O. and Olivecrona, T. (1974) Biochim. Biophys. 
Acta 369, 234-244. 
[9] Iverius,P.-H. (1971) Biochem. J. 124,677-683. 
[lo] Weber, K. and Osborn, M. (1969) J. Biol. Chem. 244, 
4406-4412. 
[ 111 Fairbanks, G., Steck, T. L. and Wallach, D. F. H. 
(1971) Biochemistry 10,2606-2617. 
[ 12] Morgan, R. G. H., Barrowman, J., Filipck Wender, H. 
and Borgstrom, B. (1968) Biochim. Biophys. Acta 167, 
355-366. 
[ 13] Wyun, J., Kothari, W., Herm, E., Mortenson, J., 
Treadwell, C. R. and Vahouny, G. V. (1969) J. Bioi. 
Chem. 244,1937-1945. 
[14] Albro, P. W. and Latimer, A. D. (1974) Biochemistry 
13,1431-1439. 
[15] Albro, P. W., Corbett, B. J. and Hass, J. R. (1976) 
Biochim. Biophys. Acfa 431,493-506. 
1161 Patton, J. S., Warner, T. G. and Benson, A. A. (1977) 
Biochim. Biophys. Acta 482, 322-330. 
54 
